Financhill
Sell
34

GPCR Quote, Financials, Valuation and Earnings

Last price:
$21.22
Seasonality move :
47.59%
Day range:
$21.15 - $22.91
52-week range:
$19.39 - $62.74
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.45x
Volume:
385.6K
Avg. volume:
815.6K
1-year change:
-43.39%
Market cap:
$1.3B
Revenue:
--
EPS (TTM):
-$2.35

GPCR Analysts' Consensus Rating

The 7 analysts providing 12-month price projections for Structure Therapeutics shares anticipate an average target of $80.15, ranging from a low estimate of $50.00 to a high estimate of $118.00. This average target implies a growth of 266.5% compared to the current stock price of $21.87.

Consensus Price Target

$80.15

Highest Price Target

$118.00

Lowest Price Target

$50.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 6 7 7

Hold 0 0 0

Sell 0 0 0
Consensus Buy Buy Buy

GPCR Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Sportradar Stock Going Up?
Why Is Sportradar Stock Going Up?

Sportradar (NASDAQ:SRAD) should be on your radar for a stock…

Is Roblox Stock a Buy, Sell or Hold?
Is Roblox Stock a Buy, Sell or Hold?

Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 21

Regencell Bioscience Holdings [RGC] is up 26.29% over the past day.

Buy
95
EXOD alert for Mar 21

Exodus Movement [EXOD] is down 1.88% over the past day.

Sell
15
FG alert for Mar 21

F&G Annuities & Life [FG] is down 4.5% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock